Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Giustiniani, 2, Padova 35128, Italy.
Europace. 2013 Mar;15(3):382-7. doi: 10.1093/europace/eus351. Epub 2012 Nov 1.
The majority of patients with pacemakers are very elderly, many being >85-years old. They often suffer from serious illnesses and have great difficulty in walking. The aim of our study was to compare remote pacemaker monitoring with in-home checks of pacemakers, in terms of applicability, efficacy, and cost in a selected population of debilitated elderly patients.
We selected 72 subjects (mean age 87 ± 8 years) among elderly debilitated patients with Medtronic pacemakers, compatible with the Carelink(®) remote monitoring system (13 patients with DDD pacemaker; 59 patients with single-lead VDD pacemaker). Remote follow-up was compared with in-home checks performed by nurses in 326 patients in similar clinical conditions. A total of 190 transmissions were received by remote monitoring (mean transmissions per month: 7.0; mean per patient: 2.6; range 1-6) during 27 months of follow-up. In this period, seven pacemakers were replaced owing to battery exhaustion, after a mean of 6.7 years from implantation. The occurrence of atrial or ventricular high-rate episodes was reported in 98 transmissions (53%). Nineteen patients died (annual mortality: 11.7%). On comparing the costs borne by the hospital for in-home checks, both for medical personnel and transportation, the estimated average saving was €32 per year per patient.
Our study shows that the remote follow-up of pacemakers is a reliable, effective, and cost-saving procedure in elderly, debilitated patients. Moreover, remote controls provided an accurate and early diagnosis of arrhythmia occurrence.
大多数起搏器患者都非常年迈,其中许多人年龄在 85 岁以上。他们通常患有严重疾病,行走困难。我们的研究目的是比较远程起搏器监测与在家中检查起搏器,在选定的衰弱老年患者人群中,比较其适用性、疗效和成本。
我们从符合 Carelink(®)远程监测系统的 Medtronic 起搏器的衰弱老年患者中选择了 72 名患者(平均年龄 87±8 岁)(13 名患者使用 DDD 起搏器;59 名患者使用单导联 VDD 起搏器)。远程随访与在相似临床条件下的 326 名患者进行的家庭检查进行了比较。在 27 个月的随访期间,通过远程监测共收到 190 次传输(平均每月传输次数:7.0;平均每人传输次数:2.6;范围 1-6)。在此期间,由于电池耗尽,在植入后平均 6.7 年更换了 7 个起搏器。在 98 次传输中报告了心房或心室高频事件(53%)。19 名患者死亡(年死亡率:11.7%)。比较医院在家中检查的成本,包括医疗人员和交通费用,估计平均每年每位患者节省 32 欧元。
我们的研究表明,远程监测起搏器是一种可靠、有效且节省成本的方法,适用于老年衰弱患者。此外,远程控制可准确、早期诊断心律失常的发生。